UCLA Hematology Oncology — Los Angeles, California

UCLA Hematology Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology Oncology has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung.

Sponsors: Daiichi Sankyo, Pfizer, Celgene.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology Oncology?

UCLA Hematology Oncology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology Oncology conducted?

UCLA Hematology Oncology has 12 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung.

Is UCLA Hematology Oncology accredited by Crixeo Clinical Trials?

UCLA Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.